The share of corresponding/leading authors in scientific publications in the US pharmacy sector was 98.36% in 2023 and is forecasted to remain steady at the same level from 2024 to 2028. There is no year-on-year variation in the forecast data, indicating a consistent trend over the next five years. This stability suggests a mature and possibly saturated authorship landscape within the pharmacy research domain.
Future trends to watch for include potential impacts of digital collaboration platforms on authorship roles, changes due to open-access policies, and evolving funding mechanisms that might influence author contribution shares. Monitoring shifts in research collaborations due to technological advances will be key.
